Flagship Pioneering, investor in Moderna raises $3.4 billion funds
Flagship Pioneering, the bioplatform company, and the venture capital investor in Moderna, today announced that it had raised additional funding of $2.23 billion, which brings its
U.S. authorizes the COVID-19 vaccine by Moderna, rollout in billions across the United States
December brought the news that we’ve all been anxiously waiting for since last twelve months; a COVID vaccine has been approved by the US FDA.
Moderna Vaccine Shows 94.5% Efficacy in Early Analysis
Get the latest updates and insights on COVID 19 vaccine here at the nation’s fastest-growing business magazine, Industry Leaders.
Pfizer launches Immunization Pilot Program for its COVID-19 Vaccine
Be the first to know about the latest COVID vaccine updates along with developments on the Pfizer vaccine here at your favorite business magazine, Industry Leaders.
US signs agreement to pay Moderna $1.5 billion for 100 million doses of vaccine
The US government wants first access to the vaccine for its citizens. The payment includes delivery of 100 million doses and incentive payments for timely delivery of the product.
Moderna Racing towards Second Phase of COVID Vaccine Trials
The COVID-19 coronavirus pandemic has affected 6 million people worldwide since it started spreading nearly six months ago. There have been 376,000 reported deaths worldwide. A c
Pharma Industry faces clinical trial woes due to Coronavirus in China
The Covid 19 Coronavirus far from being contained is finding new victims every day. With almost all parts of the world reporting cases, concerns about the far-reaching effects of t
